Amylyx drug comes up short; Sanofi names new CMO
AMX0035 missed the goals of a study in progressive supranuclear palsy. Elsewhere, Novartis and BioArctic struck a deal, and Genentech started building its first East Coast factory.
Previous Post
Plans for trusts to take on neighbourhood contracts ‘risk bankruptcy for GPs’, BMA warns
Next Post
Exploring Guidelines for Alopecia Areata
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago